Iron deficiency anaemia · adolescent and adult menstruating women
Intermittent iron supplementation (alone or with any other… showed no clear difference in iron deficiency anaemia (as defined by the presence of anaemia plus… compared with no supplementation or placebo (low certainty).
1 finding from 1 review
All‐cause morbidity · adolescent and adult menstruating women
Intermittent iron supplementation (alone or with any other… showed no clear difference in all‐cause morbidity (the most frequent event associated with the… compared with no supplementation or placebo (low certainty).
1 finding from 1 review
Side effects or other adverse events · adolescent and adult menstruating women
Intermittent iron supplementation (alone or with any other… showed no clear difference in any adverse side effects compared with no supplementation or placebo (moderate certainty).
1 finding from 1 review
Anaemia · adolescent and adult menstruating women
Intermittent iron supplementation showed no clear difference in anaemia (haemoglobin concentration below a cut‐off defined by the… compared with daily iron supplementation (moderate certainty).
1 finding from 1 review
Haemoglobin (g/dL) · adolescent and adult menstruating women
1 finding from 1 review
Paralytic wild polio cases (Change in slope at 3 years) · infants
1 finding from 1 review
no estimate extracted
1 participants
Very low
Persons with protective humoral response (Range of · infants
IPV‐OPV showed no clear difference in persons with protective humoral response (Range of compared with IPV (moderate certainty).
1 finding from 1 review
Neutralising antibodies with 2 IPV doses Geometric mean titres ( · infants
1 finding from 1 review
Persons with faecal polio excretion after OPV challenge (Range of · infants
It is very uncertain whether IPV‐OPV changes persons with faecal polio excretion after OPV challenge (Range of compared with IPV (very low certainty).
1 finding from 1 review
Vaccination coverage · infants
1 finding from 1 review
Serious adverse events (≥ 1 symptom related to study drug or not) (Range of · infants
IPV‐OPV showed no clear difference in serious adverse events (≥ 1 symptom related to study drug or not)… compared with IPV (low certainty).
1 finding from 1 review
Paralytic polio · preventing poliomyelitis
1 finding from 1 review
Vaccine‐associated paralytic polio (VAPP) cases (Range of · preventing poliomyelitis
1 finding from 1 review
Persons with protective humoral response (Range of · preventing poliomyelitis
IPV(3)‐OPV showed no clear difference in persons with protective humoral response ( compared with IPV(2)‐OPV (moderate certainty).
1 finding from 1 review
Neutralising antibodies · preventing poliomyelitis
1 finding from 1 review
Persons with faecal excretion after OPV challenge · preventing poliomyelitis
1 finding from 1 review
Vaccine‐associated paralytic polio (VAPP) cases (Range of · infants
1 finding from 1 review
no estimate extracted
1 participants
Low
Vaccination coverage · preventing poliomyelitis
1 finding from 1 review
Serious adverse events · preventing poliomyelitis
1 finding from 1 review
Persons with protective humoral response (Range of · infants
IPV‐OPV showed no clear difference in persons with protective humoral response (Range of compared with OPV (moderate certainty).
1 finding from 1 review